NeuroMetrix NUROW 深 沪
已收盘 06-22 16:00:00 美东时间
0.142
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.142
- 总市值 144.65万
- 52周最高 1.48
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.012
- 委 比 0.00%
- 总股本 1018.63万
- 历史最高 5.60
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.012
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多electroCore Announces First Quarter 2026 Financial Results
ElectroCore, Inc. reported Q1 2026 net sales of $9.6 million, a 43% year-over-year increase, driven by growth in VA prescription sales and Truvaga direct-to-consumer sales. The company also saw a 24% improvement in adjusted EBITDA loss to $2.3 million. Key highlights include VA prescription gammaCore revenue up 26%, Quell product line sales surpassing $1.0 million quarterly revenue, and Truvaga revenue growing 38% with improved marketing efficien...
05-06 20:05
electroCore Announces Full Year 2025 Financial Results and Organizational Changes
- ElectroCore announces 2025 full-year net sales of $32.0 million, up 27% from $25.2 million in 2024, driven by 25% growth in US prescription business and 97% increase in general wellness sales. - CEO Dan Goldberger to retire effective April 1, 2026; Joshua Lev named interim President and CFO; Michael Fox joins as COO. - 2026 revenue guidance targets 30% annual growth. - Conference call and webcast scheduled for March 19, 2026, at 4:30 PM EDT.
03-19 20:05
Kuehn Law Encourages PWOD, NURO, BHLB, and BRKL Investors to Contact Law Firm
NEW YORK, Dec. 18, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may see...
2024-12-18 22:03
Electrocore to Acquire NeuroMetrix Enhancing Bioelectronic Offerings
Electrocore ( ($ECOR) ) has shared an update. On December 17, 2024, electroCore...
2024-12-18 06:49
NeuroMetrix Merges with electroCore, Expands Quell Access
An update from Neurometrix ( ($NURO) ) is now available. NeuroMetrix, Inc. has ...
2024-12-18 06:49
